The first genome-wide association study revealed that risk of this disease is boosted by two common Factor H polymorphisms. Ranibizumab, or Lucentis, treats a rarer form of this disease caused by chor
The first genome-wide association study revealed that risk of this disease is boosted by two common Factor H polymorphisms. Ranibizumab, or Lucentis, treats a rarer form of this disease caused by choroidal neovascularization through Bruch's membrane. Seeing (*) curved lines in the Amsler grid test is a diagnostic for this disease. Excessive buildup of yellow accumulations called drusen can cause its "dry" form. For 10 points, name this disease in which damage to the namesake retinal region causes loss of central vision.
The first genome-wide association study revealed that risk of this disease is boosted by two common Factor H polymorphisms.
macular degeneration [accept age-related macular degeneration, AMD, or ARMD]